Status:

TERMINATED

A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18-80 years

Brief Summary

Vitamin D exerts antiproliferative and differentiating effects in cancers, including non-small cell lung cancer (NSCLC). The active form of Vitamin D is 1,25, dihydroxycholecalciferol (calcitriol) whi...

Detailed Description

This study seeks to prospectively determine the relationship between Vitamin D gene expression and median survival as a primary outcome, and the relationships between the Vitamin D receptor (VDR)/CYP2...

Eligibility Criteria

Inclusion

  • Scheduled for diagnostic bronchoscopy for suspected advanced stage lung cancer by CT/PET scanning.
  • Tumor or lymph node accessible by transbronchial needle aspiration.
  • Age 18-80.
  • All patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines.

Exclusion

  • Unstable cardiovascular disease or other systemic disease
  • Mental incompetence/active psychiatric illness
  • Medical contraindication for bronchoscopy

Key Trial Info

Start Date :

May 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT01409681

Start Date

May 1 2011

End Date

December 1 2013

Last Update

March 31 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

United States Department of Veteran's Affairs Medical Center

Ann Arbor, Michigan, United States, 48105

2

University of Michigan Cancer Center

Ann Arbor, Michigan, United States, 48109